Amid the furore over the delayed scheme, the reality is that the storage of pseudoanonymised patient data is already common practice, writes Dr David Springate. He argues that a national primary care database will bring big benefits – and says the risk of individuals’ data being de-anonymised by big pharma companies or criminals is remote. […]

Original source – Manchester Policy Blogs

Comments closed